Increased Genetic Protection Against Alzheimer’s Disease in Centenarians
Authors:
Preprint
Abstract
We constructed a polygenic protective score specific to Alzheimer’s disease (AD PPS) based on the current literature among the participants enrolled in five studies of healthy aging and extreme longevity in the US, Europe, and Asia. This AD PPS did not include variants on Apolipoprotein E (APOE) gene. Comparisons of AD PPS in different data sets of healthy agers and centenarians showed that centenarians have stronger genetic protection against AD compared to individuals without familial longevity. The current study also shows evidence that this genetic protection increases with increasingly older ages in centenarians (centenarians who died before reaching age 105 years, semi-supercentenarians who reached age 105 to 109 years, and supercentenarians who reached age 110 years and older). However, the genetic protection was of modest size: the average increase in AD PPS was approximately one additional protective allele per 5 years of gained lifetime. Additionally, we show that the higher AD PPS was associated with better cognitive function and decreased mortality. Taken together, this analysis suggests that individuals who achieve the most extreme ages, on average, have the greatest protection against AD. This finding is robust to different genetic backgrounds with important implications for universal applicability of therapeutics that target this AD PPS.Keywords
All Related Versions
- Published version: GeroScience, 48 (2), 1815.
Funding Information
- NIH (U19-AG023122)
- NIH (U19-AG063893)
- NIH (UH2/UH3 AG064704)
- NIH (R01-AG061844)
This publication has 47 references indexed in Scilit:
- Whole genome‐wide sequence analysis of long‐lived families (Long‐Life Family Study) identifies MTUS2 gene associated with late‐onset Alzheimer's diseaseAlzheimer's & Dementia, 2024
- The correlation between neuropathology levels and cognitive performance in centenariansAlzheimer's & Dementia, 2023
- Cognition, function, and prevalent dementia in centenarians and near‐centenarians: An individual participant data (IPD) meta‐analysis of 18 studiesAlzheimer's & Dementia, 2022
- Distribution of 54 polygenic risk scores for common diseases in long lived individuals and their offspringGeroScience, 2022
- The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort descriptionEuropean Journal of Epidemiology, 2018
- The Netherlands Brain Bank for Psychiatry2018
- Effect of Exceptional Parental Longevity and Lifestyle Factors on Prevalence of Cardiovascular Disease in OffspringThe American Journal of Cardiology, 2017
- The Longitudinal Aging Study Amsterdam: cohort update 2016 and major findingsEuropean Journal of Epidemiology, 2016
- Unique Lipoprotein Phenotype and Genotype Associated With Exceptional LongevityJAMA, 2003
- The genetics of exceptional human longevityJournal of Molecular Neuroscience, 2002